Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of SC Methotrexate (Metoject) vs IM Methotrexate in Psoriasis
NCT02097173Phase 1Completed
- Sponsor
- medac GmbH
- Start
- May 2013
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of methotrexate in psoriasis (2 arms), sponsored by medac GmbH. Primary endpoint: Relative Bioavailability of Methotrexate at 8 days. Started May 2013; status: completed.
02
Drugs
methotrexate
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT02097173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097173.